Filter
387
Filtered Results: 387
Text search:
JAMA
Network
Featured
Recommendations
45
New Publications
52
Language
Document type
No document type
152
Guidelines
110
Studies & Reports
85
Manuals
17
Training Material
7
Strategic & Response Plan
7
Situation Updates
4
Fact sheets
4
Resource Platforms
1
Countries / Regions
Global
16
India
16
Africa
13
Brazil
13
Russia
12
Latin America and the Carribbean
11
Western and Central Europe
11
Mozambique
8
Eastern Europe
7
Syria
6
Germany
6
East and Southern Africa
6
Ukraine
5
Angola
5
Eastern Europe and Central Asia
4
South Africa
4
Kenya
3
Rwanda
3
Nigeria
3
Philippines
3
West and Central Africa
3
Middle East and North Africa
3
Uganda
3
Liberia
3
Thailand
2
Sierra Leone
2
Guinea
2
Guinea-Bissau
2
Tanzania
2
South–East Asia Region
2
North America
2
Portugal
2
Tajikistan
1
Nepal
1
Colombia
1
Mexico
1
Turkey
1
Ghana
1
Kazakhstan
1
Canada
1
Kyrgyzstan
1
Burkina Faso
1
Afghanistan
1
Malawi
1
Zimbabwe
1
USA
1
Cambodia
1
Congo, Democratic Republic of
1
France
1
United Kingdom
1
Spain
1
Bangladesh
1
Vietnam
1
Yemen
1
Ethiopia
1
South Sudan
1
Indonesia
1
Iraq
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
93
Public Health
32
Clinical Guidelines
26
Women & Child Health
20
Pharmacy & Technologies
9
Key Resources
6
Capacity Building
1
Toolboxes
COVID-19
110
Mental Health
53
HIV
33
NCDs
27
TB
17
AMR
15
Planetary Health
11
Caregiver
7
Global Health Education
7
Rapid Response
6
Refugee
6
Ebola & Marburg
6
Health Financing Toolbox
5
Conflict
4
Disability
3
NTDs
3
Polio
3
Natural Hazards
2
Pharmacy
2
Specific Hazards
1
Cholera
1
Social Ethics
1
Zika
1
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
Prevention of stroke and transient ischemic attack includes both conventional approaches to vascular risk factor management (blood pressure lowering, cholesterol reduction with statins, smoking cessation and antiplatelet therapy)
and more specific interventions, such as carotid revascularization or...
An update from the EU Early Warning System
Global Qualitative Nursing Research March 31, 2021 Research Article Find in PubMed
https://doi.org/10.1177/23333936211005475
BMJ Global Health2020;5:e002014. doi:10.1136/bmjgh-2019-002014
Eurosurveillance
Impact Factor 5.7
June 2015
www.eurosurveillance.org
Featuring a series of articles on HIV and STI epidemiology, prevention and control among MSM in Europe
Malgré les progrès récents vers la mise au point d’un traitement hautement efficace et abordable contre le virus de l’hépatite C, beaucoup de personnes infectées par ce virus ne connaissent pas leur statut. L’Organisation mondiale de la Santé (OMS) estime qu’en 2019, 58 millions ...
Asthma is the most common non-communicable disease in children and remains one of the most common throughout the life course. The great majority of the burden of this disease is seen in low-income and middle-income countries (LMICs), which have disproportionately high asthma-related mortality relati...
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I...
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...
Slideset updated regularly to include the latest data and guidance on COVID-19 risk and management in special populations, including children and pregnant women, and persons with comorbidities.
We are IntechOpen, the world’s leading publisher of Open Access books Built by scientists, for scientists
Selection of our books indexed in the Book Citation Index in Web of ScienceTM Core Collection (BKCI)
http://dx.doi.org/10.5772/intechopen.68759
Mental disorders impose an enormous burden on society, accounting for almost one in three years lived with disability globally. •In addition to their health impact, mental disorders cause a significant economic burden due to lost economic output and the link between mental disorders and costly, po...
Interim guidance, 6 October 2021
Direct detection of SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions using lateral flow immunoassays (also known as rapid diagnostic tests, RDTs) offers a faster and less expensive method to test for SARS-CoV-2 than the reference ...
Руководство по осуществлению mhGAP
recommended
The WHO Mental Health Gap Action Programme (mhGAP) aims at scaling up mental health services in non-specialized health settings to achieve universal health coverage. The mhGAP operations manual is an integral component of the mhGAP package and supports district health managers and others responsible...
